Galectin Therapeutics Stock Technical Analysis

GALT Stock  USD 2.78  0.06  2.21%   
As of the 24th of November, Galectin Therapeutics retains the Downside Deviation of 2.95, market risk adjusted performance of 0.2067, and Risk Adjusted Performance of 0.0833. Galectin Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Galectin Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Galectin, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Galectin
  
Galectin Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Galectin Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
11.0Buy1Odds
Galectin Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Galectin analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Galectin stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Galectin Therapeutics, talking to its executives and customers, or listening to Galectin conference calls.
Galectin Analyst Advice Details
Galectin Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Galectin Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Galectin Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Galectin Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Galectin Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Galectin Therapeutics Trend Analysis

Use this graph to draw trend lines for Galectin Therapeutics. You can use it to identify possible trend reversals for Galectin Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Galectin Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Galectin Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Galectin Therapeutics applied against its price change over selected period. The best fit line has a slop of    , which means Galectin Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.16, which is the sum of squared deviations for the predicted Galectin Therapeutics price change compared to its average price change.

About Galectin Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Galectin Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Galectin Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Galectin Therapeutics price pattern first instead of the macroeconomic environment surrounding Galectin Therapeutics. By analyzing Galectin Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Galectin Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Galectin Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.

Galectin Therapeutics November 24, 2024 Technical Indicators

Most technical analysis of Galectin help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Galectin from various momentum indicators to cycle indicators. When you analyze Galectin charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Galectin Stock Analysis

When running Galectin Therapeutics' price analysis, check to measure Galectin Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galectin Therapeutics is operating at the current time. Most of Galectin Therapeutics' value examination focuses on studying past and present price action to predict the probability of Galectin Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galectin Therapeutics' price. Additionally, you may evaluate how the addition of Galectin Therapeutics to your portfolios can decrease your overall portfolio volatility.